Mechanism of three inhibitors of TACE in blocking the converting of pro-TNFα into sTNFα

Wang Zhen , Wang Yin , Zhu Kongli , Guo Lianjun , Yang Yuzhen

Current Medical Science ›› 2003, Vol. 23 ›› Issue (6) : 116 -120.

PDF
Current Medical Science ›› 2003, Vol. 23 ›› Issue (6) : 116 -120. DOI: 10.1007/BF02859931
Article

Mechanism of three inhibitors of TACE in blocking the converting of pro-TNFα into sTNFα

Author information +
History +
PDF

Abstract

The effects of inhibitors of TNFα converting enzyme (TACE) on TNFα secretion were studied to develop an approach to interfere inflammation processes. The HL-60 cell lines were stimulatedin vitro with LPS intravenously for different time to establish the cellular model of inflammation and simultaneously inducein vivo inflammation animal model by LPS The cytotoxic effects of soluble TNFα were checked using MTT colorimetric method to determine the rate of cell proliferation. The level of expression of TACE was detected by using RT-PCR, FCM and immuno-histochemical technique respectively. It was found Chinese medicine Reduqing (RDQ) could inhibit the transcription of TNFα mRNA induced by LPS stimulation (P<0.01, compared with the control). The antioligodeoxyribonucleotide (anti-ODN) of TNFα mRNA could inhibit 78.96% of TNFα secretion. The mimic peptides of TACE substrates with hydroxamine group showed potencyin vivo andin vitro against converting of pro-TNFα. It was concluded that all the three types of TACE inhibitors can regulate the expression of TACE at different levels and inhibit sTNFα secretion, indicating TACE is a novel target for inflammation therapy.

Keywords

TNFα converting enzyme / tumor necrosis factor-α / Reduqing / anti-oligodeoxyribonucleotide / peptide inhibitor

Cite this article

Download citation ▾
Wang Zhen, Wang Yin, Zhu Kongli, Guo Lianjun, Yang Yuzhen. Mechanism of three inhibitors of TACE in blocking the converting of pro-TNFα into sTNFα. Current Medical Science, 2003, 23(6): 116-120 DOI:10.1007/BF02859931

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

MossM L. Cloning of a disintegrin metalloproteinase that processes precursor tumor necrosis factor-α. Nature, 1997, 385373-373

[2]

FladH D, LoppnowH. Agonists and antagonists for LPS-induced cytokines. Immunology, 1993, 187303-303

[3]

AminA R. Regulation of tumor necrosis factor-alpha and tumor necrosis factor converting enzyme in human osteoarthritis. Osteoarthritis Cartilage, 1999, 7(4): 392-392

[4]

TakashibaS, Van DykeT, ShapiraL, et al. . Lipopolysaccharide-inducible and salicylate-sensitive nuclear factor on human necrosis factor alpha promoter. Infect Immun, 1995, 63(4): 1529-1529

[5]

BaxbaumJ D, LiuK N, LuoY, et al. . Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J Biol Chem, 1998, 273(43): 27765-27765

[6]

BlackR A, RauchC T, KozloskyC J, et al. . A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature, 1997, 385(6618): 729-729

[7]

TingboDing, LingboLi, KongliZhu, et al. . Reletionship between the increase of secretion of sTNFα induced by lipopely saccharides and enhanced expression of TACE mRNA in HL-60 cells and adhesive cells from human spleen. J Tongji Med Univ, 2001, 21(4): 265-265

[8]

FlickD A, GilfordG E. The detection of biological activity of tumor necrosis factor-α. J Immunol Methods, 1984, 68167-167

[9]

BlackR A, DurieF H, Otten-EvansC, et al. . Related specificity of matrix metalloproteinases (MMPs) and TIMP insensitivity of tumor necrosis factor-alpha (TNF-alpha) production suggest the major TNF-alpha converting enzyme is not an MMP. Biochem Biophys Res Commun, 1996, 225(2): 400-400

AI Summary AI Mindmap
PDF

94

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/